99 related articles for article (PubMed ID: 8914792)
1. A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy.
Neve RL; Geller AI
Clin Neurosci; 1995-1996; 3(5):262-7. PubMed ID: 8914792
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer into the central nervous system using herpes simplex virus-1 vectors.
Tabbaa S; Goulah C; Tran RK; Lis A; Korody R; Stachowski B; Horowitz JM; Torres G; Stachowiak EK; Bloom DC; Stachowiak MK
Folia Morphol (Warsz); 2000; 59(4):221-32. PubMed ID: 11107692
[TBL] [Abstract][Full Text] [Related]
3. The use of herpes simplex virus vectors for gene therapy in neurological diseases.
Kennedy PG; Steiner I
Q J Med; 1993 Nov; 86(11):697-702. PubMed ID: 8265768
[TBL] [Abstract][Full Text] [Related]
4. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
Geller AI; Yu L; Wang Y; Fraefel C
Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158
[TBL] [Abstract][Full Text] [Related]
5. Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting.
Wood MJ; Byrnes AP; Kaplitt MG; Pfaff DW; Rabkin SD; Charlton HM
Exp Neurol; 1994 Nov; 130(1):127-40. PubMed ID: 7821388
[TBL] [Abstract][Full Text] [Related]
6. [Herpes simplex type-1 virus-based vectors for gene therapy].
Ichikawa T; Saeki Y; Tamiya T; Chiocca EA; Ohmoto T
Nihon Rinsho; 2000 Apr; 58(4):822-7. PubMed ID: 10774201
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus type 1 amplicon vectors for the infectious delivery and expression of genomic DNA loci.
Senior SL; Wade-Martins R
Curr Opin Mol Ther; 2005 Aug; 7(4):337-45. PubMed ID: 16121699
[TBL] [Abstract][Full Text] [Related]
8. HSV trafficking and development of gene therapy vectors with applications in the nervous system.
Frampton AR; Goins WF; Nakano K; Burton EA; Glorioso JC
Gene Ther; 2005 Jun; 12(11):891-901. PubMed ID: 15908995
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus vectors for gene transfer to the nervous system.
Goins WF; Krisky D; Marconi P; Oligino T; Ramakrishnan R; Poliani PL; Fink DJ; Glorioso JC
J Neurovirol; 1997 May; 3 Suppl 1():S80-8. PubMed ID: 9179803
[TBL] [Abstract][Full Text] [Related]
10. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
11. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons.
Krisky DM; Wolfe D; Goins WF; Marconi PC; Ramakrishnan R; Mata M; Rouse RJ; Fink DJ; Glorioso JC
Gene Ther; 1998 Dec; 5(12):1593-603. PubMed ID: 10023438
[TBL] [Abstract][Full Text] [Related]
12. [Advance of gene therapy for neurological diseases by direct in vivo gene transfer].
Li BY; Liu C; Wang HX
Sheng Li Ke Xue Jin Zhan; 1996 Jul; 27(3):215-20. PubMed ID: 9772359
[TBL] [Abstract][Full Text] [Related]
13. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
[TBL] [Abstract][Full Text] [Related]
14. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
Perez MC; Hunt SP; Coffin RS; Palmer JA
Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of HSV mass distribution in a rodent brain tumor model.
Schellingerhout D; Rainov NG; Breakefield XO; Weissleder R
Gene Ther; 2000 Oct; 7(19):1648-55. PubMed ID: 11083473
[TBL] [Abstract][Full Text] [Related]
18. Delivery of herpes simplex virus amplicon-based vectors to the dentate gyrus does not alter hippocampal synaptic transmission in vivo.
Dumas T; McLaughlin J; Ho D; Meier T; Sapolsky R
Gene Ther; 1999 Oct; 6(10):1679-84. PubMed ID: 10516716
[TBL] [Abstract][Full Text] [Related]
19. Use of herpes simplex virus type 1 for transgene expression within the nervous system.
Lachmann RH; Efstathiou S
Clin Sci (Lond); 1999 Jun; 96(6):533-41. PubMed ID: 10334958
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated viral vectors for gene transfer and gene therapy.
Büeler H
Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
